SOURCE: Healthnostics, Inc.

September 07, 2011 09:45 ET

Healthnostics Reveals 2011-12 Plan

NEW YORK, NY--(Marketwire - Sep 7, 2011) - Healthnostics, Inc. (PINKSHEETS: HNSS) revealed its innovative Plan for 2011-12. The Plan is based upon the Company's Accretive Synergy Program as administered through its HNS Fund Co. division. The accretive element consists of both active and passive investments in a variety of promising and profitable fields. Some passive investments are then converted into active investments when management identifies a fit and need for its services and resources. This is the synergy element. In this way the Accretive Synergy Program provides a reservoir for potential acquisitions.

Each of the three levels of accretive investment -- passive, active, and acquisition -- provide independent revenue streams, creating a highly flexible system that brings entrepreneurial and inventive input without the accompanying costs. The Company's Machine Manufacturing subsidiary grew out of this concept and is on the verge of significantly impacting revenue. Other investments include fields such as online entertainment, e-commerce, publishing, finance, and production/producing, and these contributed to the recently announced net gain of $957,000 in the market value of HNS Fund Co. Over the next 12 months, several of these investments are expected to move from passive to active status or from active to full acquisitions.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.

Contact Information

  • Contact:
    Healthnostics, Inc.
    Investor Relations
    P. 301-956-3342
    Email Contact